Tumor Biology

, Volume 36, Issue 8, pp 6401–6408 | Cite as

Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer

  • Mingqiang KangEmail author
  • Yonghua Sang
  • Haiyong Gu
  • Liang Zheng
  • Liming Wang
  • Chao Liu
  • Yijun Shi
  • Aizhong Shao
  • Guowen Ding
  • Suocheng Chen
  • Weifeng Tang
  • Jun YinEmail author
Research Article


Worldwide, rates of esophageal cancer have been keeping highly in recent decades. Genetic variants in multiple cellular pathways might play an important role in altering risk of esophageal carcinoma. In this study, long noncoding RNAs (lncRNAs) functional single nucleotide polymorphisms (SNPs) were investigated in Chinese Han populations. We have genotyped the ANRIL rs2151280 T/C, POLR2E rs3787016 C/T, and HULC rs7763881 A/C SNPs in 380 esophageal squamous cell carcinoma (ESCC) cases and 380 cancer-free controls. POLR2E rs3787016 C/T was associated with a significantly decreased risk for ESCC (CT vs. CC: OR 0.62, 95 % CI 0.44–0.87, P = 0.005; adjusted OR 0.62, 95 % CI 0.44–0.87, P = 0.005). The other SNP, HULC rs7763881, also showed a suggestive association (AC vs. AA: OR 0.70, 95 % CI 0.50–0.98, P = 0.037; adjusted OR 0.69, 95 % CI 0.49–0.97, P = 0.031). ANRIL rs2151280 T/C SNP was not associated with risk of ESCC. In the future, larger studies with other ethnic populations, tissue-specific biological characterization, and detailed individual information should be undertaken to validate current findings.


lncRNAs Polymorphisms Esophageal cancer Molecular epidemiology 



Long noncoding RNAs


Linkage disequilibrium


Odds ratio


Confidential interval


Single nucleotide polymorphisms


Esophageal squamous cell carcinoma



We appreciate all patients who participated in this study. This study was supported in part by the National Natural Science Foundation of China (81472332, 81370001, 81300037, 81101889, 81000028, 81341006), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Fujian Province Natural Science Foundation (2013J01126, 2013J05116), Fujian Medical University professor fund (JS12008) and Fujian Province science and technology programmed fund (2012Y0030), Social Development Foundation of Zhenjiang (SH2010017), and Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102).

Conflicts of interest


Supplementary material

13277_2015_3328_MOESM1_ESM.docx (29 kb)
Table S1 (DOCX 29 kb)


  1. 1.
    Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39:925–38.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Lakhotia SC. Long non-coding RNAs coordinate cellular responses to stress. Wiley Interdisciplin Rev RNA. 2012;3:779–96.CrossRefGoogle Scholar
  4. 4.
    Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013;108:2419–25.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bierhoff H, Schmitz K, Maass F, Ye J, Grummt I. Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harb Symp Quant Biol. 2010;75:357–64.CrossRefPubMedGoogle Scholar
  6. 6.
    Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. Lincrnas act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477:295–300.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–66.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904–14.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Morris KV. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenet : Off J DNA Methylation Soc. 2009;4:296–301.CrossRefGoogle Scholar
  10. 10.
    Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;40:2004–12.PubMedGoogle Scholar
  11. 11.
    Hauptman N, Glavac D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14:4655–69.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dereure O. Role of non-coding RNA ANRIL in the genesis of plexiform neurofibromas in neurofibromatosis type 1. Ann Dermatol Venereol. 2012;139:421–2.CrossRefPubMedGoogle Scholar
  13. 13.
    Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25:1086–95.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Yang G, Lu X, Yuan L. LncRNA: A link between RNA and cancer. Biochim Biophys Acta. 1839;2014:1097–109.Google Scholar
  15. 15.
    Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 2011;32:1655–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;132:330–42.CrossRefPubMedGoogle Scholar
  17. 17.
    Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.CrossRefPubMedGoogle Scholar
  19. 19.
    Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.CrossRefPubMedGoogle Scholar
  20. 20.
    Schaeffeler E, Zanger UM, Eichelbaum M, Asante-Poku S, Shin JG, Schwab M. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: Reliable genotyping in different ethnic groups. Clin Chem. 2008;54:1637–47.CrossRefPubMedGoogle Scholar
  21. 21.
    Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703–19.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. Creb up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38:5366–83.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33:717–26.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Mingqiang Kang
    • 1
    Email author
  • Yonghua Sang
    • 2
  • Haiyong Gu
    • 3
  • Liang Zheng
    • 4
  • Liming Wang
    • 5
  • Chao Liu
    • 3
  • Yijun Shi
    • 3
  • Aizhong Shao
    • 3
  • Guowen Ding
    • 3
  • Suocheng Chen
    • 3
  • Weifeng Tang
    • 3
  • Jun Yin
    • 3
    • 6
    Email author
  1. 1.Department of Thoracic Surgery, Affiliated Union HospitalFujian Medical UniversityFuzhouChina
  2. 2.Department of Cardiothoracic SurgeryThe Second Affiliated Hospital of Soochow UniversitySuzhouChina
  3. 3.Department of Cardiothoracic SurgeryAffiliated People’s Hospital of Jiangsu UniversityZhenjiangChina
  4. 4.Department of Cardiothoracic SurgeryThe First People’s Hospital of Changzhou and The Third Affiliated Hospital of Suzhou UniversityChangzhouChina
  5. 5.Cancer Institute, Department of ChemotherapyPeople’s Hospital Affiliated to Jiangsu UniversityZhenjiangChina
  6. 6.Department of Cardiothoracic SurgeryAffiliated People’s Hospital of Jiangsu UniversityZhenjiangChina

Personalised recommendations